Corbyn Investment Management’s Pfizer PFE Stock Holding History

Corbyn Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-912	Closed	-$31K	–	90
2018 Q1	$31K	Buy	+912	New	+$31.4K	0.01%	70

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corbyn Investment Management's PFE Position: Q2 2018 in Review

Corbyn Investment Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 912 shares — an estimated $31K sold.

Corbyn Investment Management first reported a position in PFE in Q1 2018 and held it in 1 quarter. The position peaked at $31K in Q1 2018. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Corbyn Investment Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Corbyn Investment Management sold 912 Pfizer shares in Q2 2018, an estimated $31K.
Corbyn Investment Management first reported a position in Pfizer in Q1 2018 and held it in 1 quarter.
Corbyn Investment Management's Pfizer position peaked at $31K in Q1 2018.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Corbyn Investment Management's 13F filing for Q2 2018, filed 8 Aug 2018.